Clinical Trials Logo

Clinical Trial Summary

clinically assess the reversal of articaine 4% of two different concentration of vasoconcentration soft-tissue local anesthesia in pediatric dentistry using Diode Laser and Oraverse


Clinical Trial Description

Patients will be divided randomly into two groups (20 patients in each group) Group (1): Patients will be undergoing anesthesia revision by diode laser Group (2): Patients will be undergoing anesthesia revision by oraverse. Then each group will be subdivided into 2 subgroups (10 patients each) according to type of local anesthetic agent into: subgroup 1: Articaine 4% with 1:100000 epinephrin &Subgroup 2: Articaine 4% with 1:200000 epinephrin After 30 min of injection corresponding to approximate time of treatment, the patient in each group will be exposed to the reversal agent which may be diode laser or oraverse. ;


Study Design


NCT number NCT05473858
Study type Interventional
Source Al-Azhar University
Contact sara nabil, DR
Phone 00201006420998
Email snhasem@gmail.com
Status Recruiting
Phase Phase 3
Start date December 10, 2021
Completion date October 1, 2022